Showing 81 - 100 results of 512 for search '"low and middle income countries"', query time: 0.07s Refine Results
  1. 81

    Challenges and Opportunities for Data Sharing Related to Artificial Intelligence Tools in Health Care in Low- and Middle-Income Countries: Systematic Review and Case Study From Thailand by Aprajita Kaushik, Capucine Barcellona, Nikita Kanumoory Mandyam, Si Ying Tan, Jasper Tromp

    Published 2025-02-01
    “… BackgroundHealth care systems in low- and middle-income countries (LMICs) can greatly benefit from artificial intelligence (AI) interventions in various use cases such as diagnostics, treatment, and public health monitoring but face significant challenges in sharing data for developing and deploying AI in health care. …”
    Get full text
    Article
  2. 82

    Assessing the impact of antimicrobial resistance policies on antibiotic use and antimicrobial resistance-associated mortality in children and adults in low and middle-income countries: a global analysis by Günther Fink, Jay Patel, Kyaw Zay Ya

    Published 2025-02-01
    “…In recent years, many low and middle-income countries (LMICs) have implemented policies to optimise antibiotic use in both formal and informal healthcare settings. …”
    Get full text
    Article
  3. 83
  4. 84
  5. 85
  6. 86

    The evolution of health policy and systems research in 11 low- and middle-income countries and the role of the Alliance for Health Policy and Systems Research: a bibliometric analysis for 1999–2020 by Nino Paichadze, Emma K. Cook, Heather E. Rosen, Sara Kurtovic, Adnan A. Hyder

    Published 2025-01-01
    “…Abstract Objectives Given the rapid growth of the field of health policy and systems research (HPSR), it is important to monitor the research environment, especially the evolution of HPSR research outputs in low- and middle-income countries (LMICs). The objective of this study was to generate quantitative metrics to assess the production of HPSR publications and the role of the Alliance for Health Policy and Systems Research (the Alliance) grant-funded projects in 11 LMICs over the past 20 years. …”
    Get full text
    Article
  7. 87
  8. 88
  9. 89
  10. 90
  11. 91

    Economic burden of chronic obstructive pulmonary disease and post-tuberculosis sequelae in low- and middle-income countries: a database compiled from a systematic review and meta-analysis by Fabrizio Tediosi, Klaus Reither, Olivia Keiser, Alexandra Walker, Yuling Lin, Marguerite Batta, Sierra Ottilie-Kovelman, Anna Duchenko, Curdin Brugger, Robert S Wallis, Marina Antillon

    Published 2024-07-01
    “…This systematic review summarised the evidence on the costs of COPD, including post-TB diseases in low- and middle-income countries.Methods A systematic review was conducted and studies published between 1 January 2013 and 28 March 2022 (the date of the search) were identified using various electronic databases without language restrictions. …”
    Get full text
    Article
  12. 92
  13. 93
  14. 94
  15. 95
  16. 96

    Effect of short message service reminders in improving optimal antenatal care, skilled birth attendance and postnatal care in low-and middle-income countries: a systematic review and meta-analysis by Tesfahun Hailemariam, Asmamaw Atnafu, Lemma Derseh Gezie, Binyam Tilahun

    Published 2024-12-01
    “…Conclusions Short message service yielded a positive effect in improving antenatal care visit, skilled birth attendance, and postnatal care attendance in low-and middle-income countries. Short message service reminder intervention should be promoted as a tool to improve maternal health service utilization in low and middle-income countries.…”
    Get full text
    Article
  17. 97

    Immunogenicity of Two Fractional Inactivated Poliovirus Vaccine Doses vs Single Intramuscular Inactivated Poliovirus Vaccine Dose in Infants of Low- and Middle-income Countries: A Prospective Case-control Study by Kunal Kumar, Sangita Yadav, Raghvendra Singh, Archana Thakur

    Published 2024-03-01
    “…Conclusion: The seroconversion rates of f-IPV were superior to the full dose IPV and may be a cost-effective choice for low- and middle-income countries.…”
    Get full text
    Article
  18. 98
  19. 99
  20. 100